Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46, (S0924977X21003746), (10.1016/j.euroneuro.2021.07.092)]

Bernhard T. Baune, Emma Sampson, Jennie Louise, Hikaru Hori, K. Oliver Schubert, Scott R. Clark, Natalie T. Mills, Célia Fourrier

Research output: Contribution to journalComment/debatepeer-review


The authors regret that the upper IQR values reported in Table 1 for the baseline age and hsCRP were wrong for the Vortioxetine + Placebo group and for the Vortioxetine + Celecoxib group. Table 1 has been updated with the correct values. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)61-62
Number of pages2
JournalEuropean Neuropsychopharmacology
Publication statusPublished or Issued - Nov 2022
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Cite this